HTA15 An Assessment of the Evidence Published Post-HTA for Selected HER2-Positive, Early Breast Cancer Medicines, to Address Potential HTA-Body Uncertainties

Autor:	E Anastasaki, T Harding, J Ryan, A Seddik, K Dunton, M Becce, CJ Crossman-Barnes
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S506
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.04.1149
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::781c041b9475402858b470c09c47fb2c https://doi.org/10.1016/j.jval.2022.04.1149 Zobrazit plný text záznamu Full Text from ScienceDirect